Cargando…
Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer
Drug combinations can improve angiostatic cancer treatment efficacy and enable the reduction of side effects and drug resistance. Combining drugs is non-trivial due to the high number of possibilities. We applied a feedback system control (FSC) technique with a population-based stochastic search alg...
Autores principales: | Weiss, Andrea, Ding, Xianting, van Beijnum, Judy R., Wong, Ieong, Wong, Tse J., Berndsen, Robert H., Dormond, Olivier, Dallinga, Marchien, Shen, Li, Schlingemann, Reinier O., Pili, Roberto, Ho, Chih-Ming, Dyson, Paul J., van den Bergh, Hubert, Griffioen, Arjan W., Nowak-Sliwinska, Patrycja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473022/ https://www.ncbi.nlm.nih.gov/pubmed/25824484 http://dx.doi.org/10.1007/s10456-015-9462-9 |
Ejemplares similares
-
Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion
por: Nowak-Sliwinska, Patrycja, et al.
Publicado: (2012) -
A genomic screen for angiosuppressor genes in the tumor endothelium identifies a multifaceted angiostatic role for bromodomain containing 7 (BRD7)
por: van Beijnum, Judy R., et al.
Publicado: (2017) -
Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy
por: Weiss, Andrea, et al.
Publicado: (2015) -
Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization
por: Weiss, Andrea, et al.
Publicado: (2014) -
Combination of ruthenium(II)-arene complex [Ru(η(6)-p-cymene)Cl(2)(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity
por: Berndsen, Robert H., et al.
Publicado: (2017)